Hepatitis C Drugs Market & Pipeline Drugs Analysis to 2019 With special emphasis on Hepatitis C Approved Drugs, Pipeline Drugs and Clinical Trial Analysis iGATE RESEARCH Published Date: October 2014 Copyright © 2014 iGATE Research

Worldwide - Hepatitis C Drugs Market & Pipeline Drugs Analysis to 2019 – Table of Contents 1.Executive Summary 2.Hepatitis C Drugs Market & Forecast 3.Hepatitis C – Approved Drugs Sales & Forecast to Pegylated Interferon 3.1.1Pegasys 3.1.2PegIntron

3.2Interferon 3.2.1Intron A 3.3Nucleoside Analogs (Ribavirin) 3.3.1Copegus 3.3.2Rebetol 3.3.3Virazole Continue (

3.4Protease Inhibitor 3.4.1Victrelis (Boceprevir) 3.4.2Johnson and Johnson Incivek (Telaprevir) 3.4.3Vertex Incivek (Telaprevir) 3.4.4Olysio (Simeprevir/TMC435) 3.4.5Sovaldi (Sofosbuvir / GS-7977) 3.4.6Daklinza (Daclatasvir/BMS ) Continue (

4.1HCV Franchise (Bristol-Myers Squibb) 4.2HCV Franchise (AbbVie) 4.3PEG-Interferon Lambda 4.4Vaniprevir 4.5MK MK Mericitabine or RG Sunvepra (Asunaprevir) 4.8ABT-450/r + Ombitasvir (ABT-267) + Dasabuvir (ABT-333) 5. Hepatitis C – Deals & Acquisitions 4. Hepatitis C – Pipeline Drugs Sales & Forecast to 2020

6.1Roche - Pipeline Drugs Analysis 6.1.1Phase II Clinical Trials Analysis 6.1.2Phase I Clinical Trials Analysis 6.2AbbVie - Pipeline Drugs Analysis 6.2.1Phase III Clinical Trials Analysis 6.2.2Phase II Clinical Trials Analysis 6. Hepatitis C – Company Wise Pipeline Drugs Clinical Trials Analysis

6.3Gilead Sciences - Pipeline Drugs Analysis 6.3.1Phase IV Clinical Trials Analysis 6.3.2Phase III Clinical Trials Analysis 6.3.3Phase II Clinical Trials Analysis 6.3.4Phase I Clinical Trials Analysis 6.4Achillion - Pipeline Drugs Analysis 6.4.1Phase II Clinical Trials Analysis Continue (

6.5Merck - Pipeline Drugs Analysis 6.5.1Phase IV Clinical Trials Analysis 6.5.2Phase III Clinical Trials Analysis 6.5.3Phase II Clinical Trials Analysis 6.5.4Phase I Clinical Trials Analysis Continue (

6.6Tibotec / Janssen - Pipeline Drugs Analysis 6.6.1Phase IV Clinical Trials Analysis 6.6.2Phase III Clinical Trials Analysis 6.6.3Phase II Clinical Trials Analysis 6.6.4Phase I Clinical Trials Analysis 6.7Bristol-Myers Squibb (BMS) - Pipeline Drugs Analysis 6.7.1Clinical Trials Analysis Continue (

6.8Vertex - Pipeline Drugs Analysis 6.8.1Clinical Trials Analysis 6.9Genentech - Pipeline Drugs Analysis 6.9.1Clinical Trials Analysis Continue (

Source of Information iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

iGATE RESEARCH iGATE RESEARCH Phone: (India) (India) Internet: Published By

Format Report Title: Hepatitis C Drugs Market and Pipeline Analysis To Order the Report Visit: C%20Drugs%20Market%20and%20Pipeline%20Analysis For More Details Visit: Single User LicenseUS$ 900 Hard-copy Mail DeliveryUS$ 1,000 CD-ROM Mail DeliveryUS$ 950 Multi User LicenseUS$ 1,400

Order the Report iGATE RESEARCH PVT. LTD. Web: To order the Report: Contact No. : , (INDIA) For Report Related Query: Contact No. : , (INDIA)